➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Colorcon
McKinsey
Baxter
Express Scripts

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

MINOXIDIL (FOR WOMEN) Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Minoxidil (for Women)

A generic version of MINOXIDIL (FOR WOMEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Start Trial

Drug patent expirations by year for MINOXIDIL (FOR WOMEN)
Recent Clinical Trials for MINOXIDIL (FOR WOMEN)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Minnesota - Clinical and Translational Science InstitutePhase 2
Northwestern UniversityEarly Phase 1
Institute of Dermatology, ThailandPhase 4

See all MINOXIDIL (FOR WOMEN) clinical trials

US Patents and Regulatory Information for MINOXIDIL (FOR WOMEN)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
P And L MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 208092-002 Jul 27, 2017 OTC No No   Start Trial   Start Trial   Start Trial
Hi Tech Pharma MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 074731-002 May 11, 2005 OTC No No   Start Trial   Start Trial   Start Trial
Taro MINOXIDIL (FOR WOMEN) minoxidil AEROSOL, FOAM;TOPICAL 209074-002 Apr 22, 2019 OTC No No   Start Trial   Start Trial   Start Trial
Apotex Inc MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 074924-002 Apr 29, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Sight Pharms MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 074743-001 Oct 18, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
L Perrigo Co MINOXIDIL (FOR WOMEN) minoxidil SOLUTION;TOPICAL 075357-002 Jul 30, 1999 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Baxter
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.